Guardant Health
GH
#1214
Rank
NZ$33.60 B
Marketcap
NZ$253.40
Share price
4.37%
Change (1 day)
207.69%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

We have found no dividend yield history for this company